Dr Williams-Gray’s team at the University of Cambridge’s Centre for Parkinson-Plus are conducting a clinical trial of azathioprine (AZA-PD), a medication already used to treat inflammation by dampening down the immune system’s response, with the aim of slowing brain cell damage and slowing the progression of Parkinson’s.
Cure Parkinson’s is funding a sub-study of the AZA-PD clinical trial which will examine precisely how azathioprine interacts with the immune system in Parkinson’s.
How helpful was this content?
/ 5. Vote count: